Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment
European Journal of Cancer · 2026-11 · 248 · 117738
DOI: 10.1016/j.ejca.2026.117738 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von M.E. Vaccari und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vaccari, M., Salvi, S., Rossino, G., Malacrida, A., Molteni, L., Giacomo, M. D., Linciano, P., Rossi, D., Miloso, M., & Collina, S. (2026). Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment. European Journal of Cancer, 248, 117738. https://doi.org/10.1016/j.ejca.2026.117738
Vancouver
Vaccari M, Salvi S, Rossino G, Malacrida A, Molteni L, Giacomo MD, et al. Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment. European Journal of Cancer. 2026;248:117738. doi:10.1016/j.ejca.2026.117738
BibTeX
@article{Vaccari2026,
author = {Vaccari, M.E. and Salvi, S. and Rossino, G. and Malacrida, A. and Molteni, L. and Giacomo, M. Di and Linciano, P. and Rossi, D. and Miloso, M.R. and Collina, S.},
title = {Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117738},
doi = {10.1016/j.ejca.2026.117738}
}
EUVIMED